Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of the American Society of Nephrology

• Publication date

  1998-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 9848789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy.

  1997cited by this paper
• Hepatitis C virus infection in dialysis and renal transplantation.

  1997influential reference
• Uncommon side‐effects of interferon

  1997cited by this paper
• Chronic viral hepatitis--benefits of current therapies.

  1996cited by this paper
• Destruction of hepatitis C virus particles by haemodialysis.

  1996cited by this paper
• A reversible posterior leukoencephalopathy syndrome.

  1996cited by this paper
• Meta‐analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

  1996cited by this paper
• Hepatitis C virus in a hemodialysis unit: molecular evidence for nosocomial transmission.

  1996cited by this paper
• THE IMPACT OF PRETRANSPLANTATION HEPATITIS C INFECTION ON THE OUTCOME OF RENAL TRANSPLANTATION

  1995cited by this paper
• Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients.

  1995cited by this paper
• Interferon treatment for chronic hepatitis C in haemodialysis patients: Suggestions based on a small series

  1995cited by this paper
• Interferon-alpha 2b treatment of chronic hepatitis C in haemodialysis patients.

  1995cited by this paper
• Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients

  1995cited by this paper
• Interferon treatment for chronic hepatitis C virus infection in uremic patients.

  1994cited by this paper
• Interferon- 2b: A New Treatment for Polycythemia Vera

  1993cited by this paper
• Interferon-alpha 2b: a new treatment for polycythemia vera.

  1993cited by this paper
• Seizures associated with low-dose alpha-interferon.

  1990cited by this paper
• Seizures in haemodialysis patients treated with recombinant human erythropoietin.

  1989cited by this paper
• Pharmacokinetics of Interferon α‐2b in Healthy Volunteers

  1987cited by this paper
• Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro.

  1986cited by this paper
• Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro.

  1986cited by this paper
• Pharmacokinetics of human and recombinant leukocyte interferon in patients with chronic renal failure who are undergoing hemodialysis.

  1983cited by this paper
• Effects of nephrectomy on the pharmacokinetics of various cloned human interferons in the rat.

  1983cited by this paper
• Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

  1982cited by this paper
• Renal metabolism of rabbit serum infection.

  1981cited by this paper
• Renal Metabolism of Rabbit Serum Interferon

  1981cited by this paper
• Renal Filtration, Absorption and Catabolism of Human Alpha Interferon

  1981cited by this paper

• Short-term exposure with high-dose interferon-α induces apoptosis in neuroblastoma cells in G0/G1 phase of the cell-cycle.

  2025cites this paper
• Kinin B1 Receptor Mediates Renal Injury and Remodeling in Hypertension

  2022cites this paper
• Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019

  2022cites this paper
• M anagement of HCV infection in chronic kidney disease

  2022cites this paper
• Cytokine Therapy

  2021cites this paper
• The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19

  2020cites this paper
• Treatment of Hepatitis C Virus-Infected Patients with Renal Failure

  2019cites this paper
• Hepatitis C virus infection in chronic kidney disease: paradigm shift in management

  2018cites this paper
• Hepatitis C virus infection in patients with end‐stage renal disease

  2018cites this paper
• When and how can nephrologists treat hepatitis C virus infection in dialysis patients?

  2018cites this paper
• The Pharmacokinetics of Beraprost Sodium Following Single Oral Administration to Subjects With Impaired Kidney Function

  2017cites this paper
• SASLT Guidelines: Update in Treatment of Hepatitis C Virus Infection

  2016influential citation
• Dissolving microneedle-based intradermal delivery of interferon-α-2b

  2016cites this paper
• Safety and Efficacy of Pegylated Interferon Alpha-2b Monotherapy in Hepatitis C Virus-Infected Children with End-Stage Renal Disease on Hemodialysis

  2016cites this paper
• [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].

  2015cites this paper
• Hepatitis C and kidney disease: An overview and approach to management.

  2015cites this paper
• Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.

  2015cites this paper
• The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.

  2015cites this paper
• Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment

  2015cites this paper
• Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.

  2014cites this paper
• Development of a Mathematical Model to Understand, Design & Improve Oncolytic Virus Therapies

  2014cites this paper
• Factors associated with efficacy of pegylated interferon-α plus ribavirin for chronic hepatitis C after renal transplantation.

  2014cites this paper
• Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa

  2014cites this paper
• Efficacy and safety of hepatitis C antiviral therapy in moderate and severe chronic kidney disease

  2014cites this paper
• What are the Management Issues for Hepatitis C in Dialysis Patients?

  2014cites this paper
• Kinetics of Hepatitis B Virus Load During Haemodialysis Sessions and α-Interferon: A Prospective Study

  2013cites this paper
• Is early virological response as predictive of the hepatitis C treatment response in dialysis patients as in non-uremic patients?

  2013cites this paper
• Hepatitis C treatment in patients with kidney disease.

  2013cites this paper
• Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C

  2013cites this paper
• Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.

  2012cites this paper
• Hepatitis C Virus Infection and Dialysis: 2012 Update

  2012cites this paper
• Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein.

  2012cites this paper
• Chronic HCV in Patients with Renal Disease

  2012cites this paper
• Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs.

  2012cites this paper
• SASLT Practice Guidelines: Management of Hepatitis C Virus Infection

  2012cites this paper
• Treatment of Hepatitis C in Solid Organ Transplantation

  2012cites this paper
• Treatment of hepatitis C in dialysis patients.

  2012cites this paper
• Interferon Alpha Concentrations in Blood and Peritoneal Fluid During Treatment for Hepatitis C

  2012cites this paper
• Management of HCV infection in chronic kidney disease.

  2011cites this paper
• Treatment of Hepatitis C-Mediated Glomerular Disease

  2011cites this paper
• Treatment issues surrounding hepatitis C in renal transplantation: a review.

  2011cites this paper
• Hepatitis C and Kidney Transplantation

  2011cites this paper
• Dilemma of HCV Infection in Renal Transplant Recipients

  2011cites this paper
• Dilemma of HCV Infection in Renal Transplant Recipients

  2011cites this paper
• Treatment of hepatitis C virus infection in patients with end‐stage renal disease

  2011cites this paper
• Occult Hepatitis C Virus Infection: Where are We Now?

  2011cites this paper
• Treatment of hepatitis C virus infection in patients on maintenance hemodialysis: a single United Arab Emirates center experience.

  2011cites this paper
• Complete remission of renal cell carcinoma with lung metastases in two hemodialysis patients after low‐dose interferon therapy

  2011cites this paper
• Review article: Hepatitis B and dialysis

  2010cites this paper
• Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta‐analysis of clinical trials

  2010cites this paper
• Therapy with Nucleos(t)ide Analogues: Current Role in Dialysis Patients

  2010cites this paper
• Successful Treatment of Hepatitis C Virus in a Renal Transplant Recipient; Case Report and Review of the Current Literature

  2010cites this paper
• Health care-associated transmission of hepatitis B and C viruses in hemodialysis units.

  2010cites this paper
• Treatment of Hepatitis C in Renal Transplantation Candidates: A Single-Center Experience

  2010cites this paper
• Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)

  2010cites this paper
• Kidney Transplantation from Donors with a Positive Serology for Hepatitis C: The Facts and the Challenges

  2010cites this paper
• Long-Term follow up of Sustained Viral Response after Treatment of Hepatitis C with Pegylated Interferon α-2a in Hemodialysis Patients

  2009cites this paper
• Preparation and biological evaluation of a glycosylated fusion interferon directed to hepatic receptors.

  2009cites this paper
• Is {beta}-interferon a promising therapeutic option for the management of hepatitis C?

  2009cites this paper
• Transplantation in the patient with hepatitis C

  2009cites this paper
• Diagnosis, management, and treatment of hepatitis C: An update

  2009cites this paper
• Review Hepatitis C virus and kidney disease q

  2008cites this paper
• Viral Hepatitis in Elderly Haemodialysis Patients

  2008cites this paper
• Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV

  2008cites this paper
• The Management of Viral Hepatitis in CKD Patients: An Unresolved Problem

  2008cites this paper
• Hepatitis C Infection in Patients with Chronic Kidney Disease

  2008cites this paper
• Hepatitis B Virus Infection and the Dialysis Patient

  2008cites this paper
• Therapeutic Aspects of Hepatitis C in Hemodialysis Patients

  2008cites this paper
• Antiviral therapy of hepatitis C in chronic kidney diseases: meta‐analysis of controlled clinical trials

  2008cites this paper
• Kinetics of hepatitis B virus load and haemodialysis: a prospective study

  2008cites this paper
• Upregulation of Myxovirus-resistance Protein A: A Possible Marker of Type I Interferon Induction in Systemic Sclerosis

  2008cites this paper
• Chapter 30 – Liver Disease in Renal Transplant Recipients

  2008cites this paper
• Type I interferon-dependent gene MxA in perinatal HIV-infected patients under antiretroviral therapy as marker for therapy failure and blood plasmacytoid dendritic cells depletion

  2008cites this paper
• [Chronic viral hepatitis and kidney failure].

  2008cites this paper
• Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms.

  2008cites this paper
• Long-term efficacy of pegylated interferon alpha-2a in HCV-positive hemodialysis patients.

  2008cites this paper
• Hepatitis C virus-related kidney disease: an overview.

  2008cites this paper
• Hepatitis C virus infection in haemodialysis and kidney transplant patients

  2008cites this paper
• Hepatitis B Virus Infection in the Dialysis Population: Current Perspectives

  2008cites this paper
• A Case Report of Interferon β Monotherapy for High Hepatitis C Viral Load in Dialysis Patients

  2007cites this paper
• Hepatitis C among Hemodialysis Patients: A Review on Epidemiologic, Diagnostic, and Therapeutic Features

  2007cites this paper
• [Treatment of hepatitis C in patients on renal replacement therapy].

  2007cites this paper
• Treatment of Hepatitis C Virus Infection in Patients before and after Renal Transplantation

  2007cites this paper
• Hepatitis C in Dialysed Patients – What Is the Current Optimal Treatment?

  2007cites this paper
• Treatment of Hepatitis C in Hemodialysis Patients with Pegylated Interferon α-2a as Monotherapy

  2007cites this paper
• Use of hepatitis C–positive donors for kidney transplantation

  2007cites this paper
• Upregulation of a Small Subset of Genes Drives Type I Interferon-Induced Antiviral Memory

  2007cites this paper
• The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.

  2007cites this paper
• Interferon‐based therapy for dialysis patients with chronic hepatitis C: Progress and challenges (Editorial)

  2007cites this paper
• Hepatitis C in dialysis patients.

  2007cites this paper
• Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.

  2007cites this paper
• Treatment of patients with chronic hepatitis C before and after renal transplantation

  2007cites this paper
• A hepatitis C-vírusfertozés terápiája vesepótló kezelésben részesülo betegekben

  2007cites this paper
• Interferon monotherapy of chronic hepatitis C in dialysis patients: meta‐analysis of clinical trials

  2007cites this paper
• Aspectos evolutivos da hepatite C em pacientes renais crônicos em hemodiálise no sudoeste do Paraná

  2006cites this paper
• Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.

  2006cites this paper
• Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C

  2006cites this paper
• Chronic hepatitis C virus infection in renal transplant: treatment and outcome

  2006cites this paper
• Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis.

  2006cites this paper
• American Gastroenterological Association technical review on the management of hepatitis C.

  2006cites this paper